Myelodysplastic Syndrome: Managing Risk and Complications

Myelodysplastic Syndrome: Managing Risk and Complications

Episodes

Specialty:

All

Year:

All

EP. 1: Understanding the Recent WHO MDS Classification Updates

January 5th 2017

EP. 2: Accurate Risk Assessment in MDS

January 5th 2017

EP. 3: MDS: When the Prognostic Models Fall Short

January 5th 2017

EP. 4: Quality of Life in Transfusion-Dependent MDS

January 5th 2017

EP. 5: Monitoring for Iron Overload in Transfusion-Dependent MDS

January 5th 2017

EP. 6: Evidence With Iron Chelation Therapy in MDS

January 5th 2017

EP. 7: Patient Selection Considerations With Iron Chelation Therapy in MDS

January 5th 2017

EP. 8: Considering Lenalidomide in Non-Del 5q MDS

January 5th 2017

EP. 9: Sequencing Strategies in Low-Risk MDS

January 5th 2017

EP. 10: Hypomethylating Agents in Low-Risk MDS

January 5th 2017

EP. 11: Emerging Therapies in Low-Risk MDS

January 5th 2017

EP. 12: Transplantation Candidacy in MDS

January 5th 2017

EP. 13: MDS: Before and After Stem Cell Transplantation

January 5th 2017

Trending on OncLive

FDA Receives BLA for Etentamig in R/R Multiple Myeloma

Breaking Down Key Lung Cancer Data at ESMO 2026 With Drs Santos and Halmos

Basser Center for BRCA Awards 2026 Global Prize to Judy Garber

Petosemtamab Plus Pembrolizumab Hits Phase 3 OS, ORR Primary End Points in PD-L1+ R/M HNSCC

Sac-TMT Plus Pembrolizumab Improves PFS in PD-L1–Negative Nonsquamous NSCLC